Vanta Bioscience Limited

BSE:540729 Stock Report

Market Cap: ₹268.1m

Vanta Bioscience Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Dopesh Mulakala

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.7yrs
CEO ownership7.3%
Management average tenure3.1yrs
Board average tenure7.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dopesh Mulakala's remuneration changed compared to Vanta Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-₹38m

Jun 30 2024n/an/a

-₹31m

Mar 31 2024n/an/a

-₹23m

Dec 31 2023n/an/a

-₹34m

Sep 30 2023n/an/a

-₹45m

Jun 30 2023n/an/a

-₹55m

Mar 31 2023₹250kn/a

-₹65m

Dec 31 2022n/an/a

-₹45m

Sep 30 2022n/an/a

-₹25m

Jun 30 2022n/an/a

-₹12m

Mar 31 2022₹3mn/a

₹882k

Dec 31 2021n/an/a

₹2m

Sep 30 2021n/an/a

₹4m

Jun 30 2021n/an/a

₹4m

Mar 31 2021₹3mn/a

₹4m

Dec 31 2020n/an/a

₹5m

Sep 30 2020n/an/a

₹5m

Jun 30 2020n/an/a

₹8m

Mar 31 2020₹3mn/a

₹10m

Dec 31 2019n/an/a

₹10m

Sep 30 2019n/an/a

₹9m

Jun 30 2019n/an/a

₹8m

Mar 31 2019₹3m₹3m

₹7m

Dec 31 2018n/an/a

₹5m

Sep 30 2018n/an/a

₹3m

Jun 30 2018n/an/a

₹2m

Mar 31 2018₹3m₹3m

₹273k

Compensation vs Market: Insufficient data to establish whether Dopesh's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Dopesh's compensation has been consistent with company performance over the past year.

CEO

Dopesh Mulakala (39 yo)

8.7yrs

Tenure

Mr. Dopesh Raja Mulakala has been Managing Director of Vanta Bioscience Limited since April 18, 2017 and its Director since April 29, 2016. He served as Interim Compliance Officer at Vanta Bioscience Limit...

Leadership Team

NamePositionTenureCompensationOwnership
Dopesh Mulakala
MD & Directorno datano data7.26%
₹ 19.5m
Venkata Sathya Dokka
Chief Financial Officer3.1yrs₹972.63kno data
Mangesh Joshi
Vice President of HR & Admin7.6yrsno datano data
Sangeetha Choudhary
Company Secretary & Compliance Officerless than a yearno datano data

3.1yrs

Average Tenure

Experienced Management: 540729's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dopesh Mulakala
MD & Director8.7yrsno data7.26%
₹ 19.5m
Kartini Binti Abdul Manaf
Independent Non-Executive Director1.5yrsno datano data
Padmanabhuni Appaji
Independent Director7.6yrsno datano data
Kathyayani Gonuguntla
Independent Director7.6yrsno datano data
Yogeswara Danda
Independent Director5.6yrsno datano data

7.6yrs

Average Tenure

69yo

Average Age

Experienced Board: 540729's board of directors are considered experienced (7.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 21:28
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vanta Bioscience Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution